Case Report: Sustained Partial Response to Thrombopoietin-Receptor Agonist-Romiplostimin Therapy of Refractory Chronic Immune Thrombocytopenia
/ 0
- Details
- Category: Vol. 83, September 2015
- Hits: 520
Case Report: Sustained Partial Response to Thrombopoietin-Receptor Agonist-Romiplostimin Therapy of Refractory Chronic Immune Thrombocytopenia, ABDULMONEIM S.M. JAMIL
Abstract
In spite of the multiple potential therapeutic modalities for the management of refractory chronic Immune Thromb-ocytopenia (ITP), still there are no solid protocols in this respect. The presented case fulfills the recent international consensus reports of refractory chronic ITP. It has lastly showed sustained partial response to therapy with the Throm-bopoietin-Receptor Agonist (Tpo-RA), romiplostim or Nplate.